Plus Vitech is in a strategic position to carry out innovative and advantageous improvements of the liquid biopsy, the companion diagnostic and the treatment field.

Our company specializes in circulating tumor DNA (ctDNA) and biomarker analyses from a blood sample, known as a liquid biopsy. This kind of biopsy will provide an easier process for doctors and patients to implement responsive, personalized, and effective treatment solutions.

Furthermore, the target gene will be a promising opportunity to discover and develop treatment agents against different types of cancer. The company is developing small molecule entities and monoclonal antibodies against this gene, which allow us to effectuate drug discovery and development projects in cancer and other human diseases.